A Call for Gene Expression Analysis in Whole Blood of Patients With Rheumatoid Arthritis (RA) as a Biomarker for RA-Associated Interstitial Lung Disease

Abstract

ObjectiveRheumatoid arthritis (RA)-associated interstitial lung disease (ILD) is one of the most common and prognostic organ manifestations of RA. Therefore, to allow effective treatment, it is of crucial importance to diagnose RA-ILD at the earliest possible stage. So far, the gold standard of early detection has been high-resolution computed tomography (HRCT) of the lungs. This procedure involves considerable radiation exposure for the patient and is therefore unsuitable as a routine screening measure for ethical reasons. Here, we propose the analysis of characteristic gene expression patterns as a biomarker to aid in the early detection and initiation of appropriate, possibly antifibrotic, therapy.MethodsTo investigate unique molecular patterns of RA-ILD, whole blood samples were taken from 12 female patients with RA-ILD (n = 7) or RA (n = 5). The RNA was extracted, sequenced by RNA-Seq, and analyzed for characteristic differences in the gene expression patterns between patients with RA-ILD and those with RA without ILD.ResultsThe differential gene expression analysis revealed 9 significantly upregulated genes in RA-ILD compared to RA without ILD:arginase 1(ARG1),thymidylate synthetase(TYMS),sortilin 1(SORT1),marker of proliferation Ki-67(MKI67),olfactomedin 4(OLFM4), baculoviral inhibitor of apoptosis repeat containing 5(BIRC5),membrane spanning 4-domains A4A(MS4A4A),C-type lectin domain family 12 member A(CLEC12A), and thelong intergenic nonprotein coding RNA(LINC02967).ConclusionAll gene products of these genes (except forLINC02967) are known from the literature to be involved in the pathogenesis of fibrosis. Further, for some, a contribution to the development of pulmonary fibrosis has even been demonstrated in experimental studies. Therefore, the results presented here provide an encouraging perspective for using specific gene expression patterns as biomarkers for the early detection and differential diagnosis of RA-ILD as a routine screening test.